100 results
8-K
EX-99.1
ADVM
Adverum Biotechnologies Inc
9 May 24
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
4:10pm
designation from the European Medicines Agency and the Innovation Passport from the United Kingdom’s Medicines and Healthcare Products Regulatory
424B3
ADVM
Adverum Biotechnologies Inc
20 Mar 24
Prospectus supplement
5:04pm
, including Commodore Capital Master LP, FMR LLC and Venrock Healthcare Capital Partners III, L.P., and/or their affiliates, are party to the Securities … BioCapital, LP (9)
628 Middlefield Road
Palo Alto, CA 94031
Entities affiliated with Venrock Healthcare Capital Partners (10)
7 Bryant Park, 23rd Floor
New
8-K
EX-99.1
jvr7l6gy30
18 Mar 24
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
4:08pm
8-K
08je8m w6
5 Feb 24
Entry into a Material Definitive Agreement
5:03pm
8-K/A
iqqrhfz32
4 Dec 23
Departure of Directors or Certain Officers
4:09pm
8-K
EX-99.1
6yo586m
9 Nov 23
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
4:07pm
8-K
s503jjg47eof8turem
6 Nov 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-99.1
oervpdn0k
10 Aug 23
Adverum Biotechnologies Completes Enrollment of Phase 2 LUNA Trial in Wet AMD and Reports Second Quarter 2023 Financial Results
4:09pm
8-K
uc91khlfmzkf962tp
4 Aug 23
Departure of Directors or Certain Officers
4:18pm
8-K
EX-99.1
3ji1jy
11 May 23
Adverum Biotechnologies Reports First Quarter 2023 Financial Results
4:10pm